[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
United Kingdom House of Lords Decisions |
||
You are here: BAILII >> Databases >> United Kingdom House of Lords Decisions >> American Cyanamid Co (No 1) v Ethicon Ltd [1975] UKHL 1 (05 February 1975) URL: http://www.bailii.org/uk/cases/UKHL/1975/1.html Cite as: [1977] FSR 593, [1975] UKHL 1, [1975] 2 WLR 316, [1975] AC 396, [1975] 1 All ER 504 |
[New search] [Context] [Printable version] [Buy ICLR report: [1975] 2 WLR 316] [Buy ICLR report: [1975] AC 396] [Help]
Die Mercurii, 5° Februarii 1975
Guidelines set out in this case to establish whether an applicant has an adequate case for the granting of an interlocutory injunction. The guidelines consider:
• Whether the claimant had a strong or merely an arguable case.
• The adequacy of damages as a remedy.
• The balance of convenience.
• Whether the status quo should be maintained.
Parliamentary
Archives,
HL/PO/JU/4/3/1262
HOUSE OF LORDS
v.
ETHICON LIMITED
Lord Diplock
Viscount
Dilhorne
Lord
Cross of Chelsea
Lord
Salmon
Lord
Edmund-Davies
Lord Diplock
MY LORDS,
This interlocutory appeal
concerns a patent for the use as absorbable
surgical sutures of
filaments made of a particular kind of chain polymer
known as "
a polyhydroxyacetic ester " (" PHAE "). These are
sutures of
a kind that disintegrate and are absorbed by the human
body once they
have served their purpose. The Appellants ("
Cyanamid "), an American
Company, are the registered
proprietors of the patent. Its priority date
in the United Kingdom
is October 2nd, 1964. At that date the absorbable
sutures in use
were of natural origin. They were made from animal
tissues
popularly known as catgut. The Respondents (" Ethicon "), a
sub-
sidiary of another American Company, were the dominant
suppliers of
catgut sutures in the U.K. market.
Cyanamid introduced their
patented product in 1970. The chemical sub-
stance of which it is
made is a homo-polymer, i.e. all the units in the chain,
except
the first and the last (" the end stabilisers"), consist of
glycolide
radicals. Glycolide is the radical of Glycolic acid,
which is another name
for hydroxyacetic acid. By 1973 this product
had succeeded in capturing
some 15 per cent, of the U.K. market
for absorbable surgical sutures. Faced
with this competition to
catgut, Ethicon who supplied 80 per cent, of the
market were
proposing to introduce their own artificial suture (" XLG
").
The chemical substance of which it is made is not a
homopolymer but a
copolymer, i.e. although 90 per cent, by weight
of the units in the chain
consist of glycolide radicals, the
remaining 10 per cent, are lactide radicals,
which are similar in
chemical properties to glycolide radicals but not identical
in
chemical composition.
Cyanamid contend the XLG
infringes their patent, of which the principal
claim is " A
sterile article for the surgical repair or replacement of living
"
tissue, the article being readily absorbable by living tissue and
being formed
" from a polyhydroxyacetic ester." As is
disclosed in the body of the patent,
neither the substance PHAE
nor the method of making it into filaments was
new at the priority
date. Processes for manufacturing filaments from PHAE
had been the
subject of two earlier U.S. patents in 1953 (Lowe) and
1954
(Higgins). The invention claimed by Cyanamid thus consisted
of the
discovery of a new use for a known substance.
On 5th March, 1973, Cyanamid
started a quia timet action against Ethicon
for an
injunction to restrain the threatened infringement of their patent
by
supplying sutures made of XLG to surgeons in the United
Kingdom. On
the same day they gave notice of motion for an
interlocutory injunction.
Voluminous affidavits and exhibits were
filed on behalf of each party. The
hearing of the motion before
Graham J. lasted three days. On 30th July,
1973, he granted an
interlocutory injunction upon the usual undertaking
in damages by
Cyanamid.
The question whether the use of
XLG as an absorbable surgical suture
is an infringement of
Cyanamid's patent depends upon the meaning to be
given to the
three words " a polyhydroxyacetic ester " in the principal
claim.
2
Cyanamid's contention is that at the date of publication
of the patent those
words were used as a term of art in the
chemistry of polymerisation not only
in the narrower meaning of a
homopolymer of which the units in the chain,
apart from the end
stabilisers, consisted solely of glycolide radicals but also
in
the broader meaning of a copolymer of which up to 15 per cent, of
the
units in the chain would be lactide radicals; and that what
was said in the
body of the patent made it clear that in the claim
the words were used in
this wider meaning.
Ethicon's first contention is that the words " a
polyhydroxyacetic ester "
in the principal claim bear the
narrower meaning only, viz. that they are
restricted to a
homopolymer of which all the units in the chain except the
end
stabilisers consist of glycolide radicals. In the alternative, as
commonly
happens where the contest is between a narrower and a
wider meaning in
a patent specification, they attack the validity
of the patent, if it bears the
wider meaning, on the grounds of
inutility, insufficiency, unfair basis and
false suggestion. These
objections are really the obverse of their argument
in favour of
the narrower construction. They are all different ways of saying
that
if the claim is construed widely it includes copolymers which will
not
have as surgical sutures the characteristics described in the
body of the patent.
Ethicon also attack the validity of the patent
on the ground of obviousness.
Both Graham J. and the Court of Appeal felt constrained
by authority to
deal with Cyanamid's claim to an interlocutory
injunction by considering
first whether, upon the whole of the
affidavit evidence before them, a prima
facie case of
infringement had been made out. As Russell L.J. put it in
the
concluding paragraph of his reasons for judgment with which the
other
members of the court agreed: —" If there be no
prima facie case on the
" point essential to entitle
the plaintiff to complain of the defendant's
" proposed
activities, that is the end of any claim to interlocutory relief."
" Prima facie case " may in some
contexts be an elusive concept, but the
sense in which it was
being used by Russell L.J. is apparent from an earlier
passage in
his judgment. After a detailed analysis of the conflicting
expert
testimony he said: —" I am not satisfied on the
present evidence that on the
" proper construction of this
specification, addressed as it is to persons
" skilled in the
relevant art or science, the claim extends to sterile surgical
"
sutures produced not only from a homopolymer of glycolide but also
from
" a copolymer of glycolide and up to 15 per cent, of
lactide. That is to say
" that I do not consider that a prima
facie case of infringement is established."
In effect what the Court of Appeal was doing was trying
the issue of
infringement upon the conflicting affidavit evidence
as it stood, without
the benefit of oral testimony or
cross-examination. They were saying " If we
" had to
give judgment in the action now without any further evidence we
"
should hold that Cyanamid had not satisfied the onus of proving that
their
" patent would be infringed by Ethicon's selling
sutures made of XLG." The
Court of Appeal accordingly did not
find it necessary to go into the questions
raised by Ethicon as to
the validity of the patent or to consider where the
balance of
convenience lay.
Graham J. had adopted the same approach as the Court of
Appeal; but,
upon the same evidence he had come to the contrary
conclusion on the issue
of infringement. He considered that on the
evidence as it stood Cyanamid
had made out a " strong prima
facie case" that their patent would be
infringed by
Ethicon's selling sutures made of XLG. He then went on to
deal
briefly with the attack upon the validity of the patent and came to
the
conclusion that upon the evidence before him none of the
grounds of
invalidity advanced by Ethicon was likely to succeed.
He therefore felt
entitled to consider the balance of convenience.
In his opinion it lay in
favour of maintaining the status quo
until the trial of the action. So he
granted Cyanamid an
interlocutory injunction restraining Ethicon from
infringing the
patent until the trial or further order.
The grant of an interlocutory injunction is a remedy
that is both temporary
and discretionary. It would be most
exceptional for your Lordships to give
leave to appeal to this
House in a case which turned upon where the balance
3
of convenience lay. In the
instant appeal, however, the question of the
balance of
convenience, although it had been considered by Graham J. and
decided
in Cyanamid's favour, was never reached by the Court of Appeal.
They
considered that there was a rule of practice so well established as
to
constitute a rule of law that precluded them from granting any
interim
injunction unless upon the evidence adduced by both the
parties on the hear-
ing of the application the applicant had
satisfied the court that on the balance
of probabilities the acts
of the other party sought to be enjoined would, if
committed,
violate the applicant's legal rights. In the view of the Court
of
Appeal the case which the applicant had to prove before any
question of
balance of convenience arose was "prima facie
" only in the sense that the
conclusion of law reached by
the court upon that evidence might need to be
modified at some
later date in the light of further evidence either detracting
from
the probative value of the evidence on which the court had acted
or
proving additional facts. It was in order to enable the
existence of any such
rule of law to be considered by your
Lordships' House that leave to appeal
was granted.
4
sought to be achieved by giving
to the court discretion to grant such injunctions
would be
stultified if the discretion were clogged by a technical rule
forbidding
its exercise if upon that incomplete untested evidence
the court evaluated the
chances of the plaintiff's ultimate
success in the action at 50 per cent, or less,
but permitting its
exercise if the court evaluated his chances at more than 50
percent.
The notion that it is incumbent
upon the court to undertake what is in effect
a preliminary trial
of the action upon evidential material different from that
upon
which the actual trial will be conducted, is, I think, of
comparatively
recent origin, though it can be supported by
references in earlier cases to the
need to show " a
probability that the plaintiff is entitled to relief " (Preston
v.
Luck 27 Ch.D. 497 per Cotton L.J. at p. 506) or "
a strong prima facie case
" that the right which he
seeks to protect in fact exists " (Smith v. Grigg
Limited
[1924] 1 K.B. 655 per Atkin L.J. at p. 659). These are to be
contrasted
with expressions in other cases indicating a much less
onerous criterion, such
as the need to show that there is "
certainly a case to be tried " (Jones v.
Pacaya
Rubber and Produce Company, Limited [1911] 1 KB 445 per
Buckley
L.J. at p.457) which corresponds more closely with what
judges
generally treated as sufficient to justify their
considering the balance of
convenience upon applications for
interlocutory injunctions, at any rate up
to the time when I
became a member of your Lordships' House.
5
disclose that the plaintiff has
any real prospect of succeeding in his claim for
a permanent
injunction at the trial, the court should go on to consider
whether
the balance of convenience lies in favour of granting or
refusing the inter-
locutory relief that is sought.
6
Graham J. did so and came to the conclusion that the
balance of con-
venience lay in favour of his exercising his
discretion by granting an inter-
locutory injunction. As Patent
Judge he has unrivalled experience of
pharmaceutical patents and
the way in which the pharmaceutical industry
is carried on.
Lacking in this experience, an Appellate Court should be
hesitant
to over-rule his exercise of his discretion, unless they are
satisfied that
he has gone wrong in law.
The factors which he took into consideration and, in my
view properly,
were that Ethicon's sutures XLG were not yet on the
market; so they had no
business which would be brought to a stop
by the injunction ; no factories
would be closed and no
work-people would be thrown out of work. They
held a dominant
position in the United Kingdom market for absorbent surgical
sutures
and adopted an aggressive sales policy. Cyanamid on the other
hand
were in the course of establishing a growing market in PHAE
surgical sutures
which competed with the natural catgut sutures
marketed by Ethicon. If
Ethicon were entitled also to establish
themselves in the market for PHAE
absorbable surgical sutures
until the action is tried, which may not be for
two or three years
yet, and possibly thereafter until the case is finally
disposed of
on appeal, Cyanamid, even though ultimately successful in
proving
infringement, would have lost its chance of continuing to
increase
its share in the total market in absorbent surgical
sutures which the continua-
tion of an uninterrupted monopoly of
PHAE sutures would have gained for
it by the time of the expiry of
the patent in 1980. It is notorious that new
pharmaceutical
products used exclusively by doctors or available only
on
prescription take a long time to become established in the
market, that much
of the benefit of the monopoly granted by the
patent derives from the fact
that the patented product is given
the opportunity of becoming established
and this benefit continues
to be reaped after the patent has expired.
In addition there was a special factor to which Graham
J. attached
importance. This was that, once doctors and patients
had got used to
Ethicon's product XLG in the period prior to the
trial, it might well be
commercially impracticable for Cyanamid to
deprive the public of it by
insisting on a permanent injunction at
the trial, owing to the damaging effect
which this would have upon
its goodwill in this specialised market and
thus upon the sale of
its other pharmaceutical products.
I can see no ground for interfering in the Learned
Judge's assessment of
the balance of convenience or for
interfering with the discretion that he
exercised by granting the
injunction. In view of the fact that there are
serious questions
to be tried upon which the available evidence is
incomplete,
conflicting and untested, to express an opinion now as
to the prospects of
success of either party would only be
embarrassing to the Judge who will
have eventually to try the
case. The likelihood of such embarrassment
provides an additional
reason for not adopting the course that both Graham
J. and the
Court of Appeal thought they were bound to follow, of dealing
with
the existing evidence in detail and giving reasoned assessments of
their
views as to the relative strengths of each party's cases.
I would allow the appeal and restore the order of Graham J.
Viscount Dilhorne
MY LORDS,
7
Lord Cross of Chelsea
MY LORDS,
Lord Salmon
MY LORDS,
Lord Edmund-Davies
MY LORDS,
For the reasons given by my
noble and learned friend, Lord Diplock,
I would also allow this
appeal.
317330 Dd 896252 120 1/75 St S